KR20140085297A - Hair treatment agent - Google Patents

Abstract

A challenge of the present invention is a hair treatment agent which mitigates the transformation efficiency of a hair shape while reducing hair damage when treating a perm. The challenge is resolved by the hair treatment agent which is formed by mixing a glycerol derivative (I) represented in a formula (I) or a polyoxyprophlene alkyl ether (II) represented in a formula (II) to be equal to or less than 4.0 wt% in a total weight and is used as a preprocessing agent for perm or a first agent for perm. Gly-[O{(PO)x(EO)y}-(BO)zH]_3 (I) [Gly indicates a glycerol residue except a hydroxyl group, PO indicates an oxypropylene group, EO indicates an oxyethylene group, BO indicates an oxy-butyl group, x is equal to or more than 3 and equal to or less than 7, y is equal to or more than 5 and equal to or less than 10, and z is equal to or more than 1 and equal to or less than 5.] Formula (II) [n is equal to or more than 13 and equal to or less than 20 and m indicates that an average additional mole number is equal to or more than 10 and equal to or less than 20.].

Description

Hair treatment agent {HAIR TREATMENT AGENT}

The present invention relates to a hair treatment agent used as a pretreatment agent for perm or a first agent for perm used before perm treatment for modifying hair shape.

In the perming treatment for performing the permanent waving treatment or the waxing treatment for imparting a wave shape to the hair, application of the first preparation for perm containing the reducing agent to the hair and application of the second preparation for perm containing the oxidizing agent to the hair . The disulfide bond of the hair is cleaved by the reducing action of the first preparation for perm, and the disulfide bond of the hair is formed by the oxidizing action of the second preparation for perm. These reduction and oxidation are the principle in the perming treatment for deforming the hair shape, and in the perming treatment accompanied by the chemical reaction, it is easy to give damage to the hair.

In order to reduce hair damage in perm treatment, a pretreatment agent applied before perm treatment may be used. There is also a proposal to realize reduction of hair damage by the first preparation for perm using a raw material to be compounded (Patent Document 1 discloses a method for producing a hair cosmetic composition containing a specific phosphoric ester, an aliphatic alcohol, a nonionic surfactant, and a cationic surfactant Composition is disclosed, and PPG-15 stearyl is added as a specific example).

Patent Document 1: Japanese Patent Application Laid-Open No. 2008-290971

The reduction of the hair damage is basically to suppress the hair reducing reaction by the first agent. This suppression suppresses the cleavage of the disulfide bond, and therefore, it is likely to lead to a decrease in the deformation efficiency of the hair shape. In other words, both the suppression of the reduction reaction and the improvement of the deformation efficiency of the hair shape often become difficult.

In view of the above circumstances, it is an object of the present invention to provide a hair treatment agent capable of improving hair strain deformation efficiency while reducing hair damage in perm treatment.

As a result of intensive studies conducted by the present inventors, it has been found that the use of a pre-treatment agent for pharma or a first preparation for perm containing a predetermined amount of a specific glycerin derivative or polyoxypropylene alkyl ether can reduce hair damage, And the efficiency is also improved, thereby completing the present invention.

That is, the hair treating agent according to the present invention is used as a first preparation for perms containing a pretreatment agent or a reducing agent for perms, and is a glycerin derivative (I) represented by the following general formula (I) or a general formula (II) (I) and the polyoxypropylene alkyl ether (II) are contained in an amount of 4.0 mass% or less, based on the total amount of the glycerin derivative (I) and the polyoxypropylene alkyl ether

Gly- [O {(PO) x (EO) y} - (BO) zH] ₃ (I)

PO represents an oxypropylene group, EO represents an oxyethylene group, BO represents an oxybutylene group, and x represents an average addition mole number of PO (hereinafter referred to as " oxyglyceryl group " Y is an average addition mole number of EO, z is an average addition mole number of BO, x is 3 or more and 7 or less, y is 5 or more and 10 or less, and z is 1 or more and 5 or less.

[In the above general formula (II), n represents 13 or more and 20 or less, and m represents an average addition mole number of 10 or more and 20 or less.

The hair treatment agent according to the present invention may further contain polyoxybutylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8EO.) (Represented by the following formula (Ia)) as the glycerin derivative 5P.O.) may be blended.

Gly- [O {(PO) ₅ (EO) ₈ } - (BO) ₃ H] ₃ (Ia)

The hair treatment agent according to the present invention may be any one that is used as a pretreatment agent for shamanism correction used before shaman correction or as a first preparation for shamanism correction used in shaman correction.

According to the hair treating agent used as the pretreatment agent for pharma or the first preparation for perming agent according to the present invention, since a predetermined amount of a specific glycerin derivative or polyoxypropylene alkyl ether is blended, it is possible to reduce hair damage, So that the deformation efficiency of the optical fiber is also improved.

The hair treatment agent according to the present invention will be described below based on the pretreatment for perming agent according to the first embodiment and the first agent for perming agent according to the second embodiment. The term " perm " is a process using a perming agent. The term " pharmacological agent " is a concept that includes cosmetics such as a curling agent that keeps the external shape of a medical device and a hair shaping agent, and it is a concept that a hair such as a wave, a wave, And the like.

(Pretreatment agent for perm)

The pretreatment agent for pharma according to the first embodiment of the present invention is one in which a specific glycerin derivative (glycerin derivative (I)) or a specific polyoxypropylene alkyl ether (POP alkyl ether (II)) is blended in water , Such as 50 mass% or more). In the pretreatment agent for pharma according to the present embodiment, a raw material to be blended with a known pretreatment agent for pharma is appropriately compounded as an arbitrary raw material.

The glycerin derivative (I)

The glycerin derivative (I) is represented by the following general formula (I) and can be obtained by adding ethylene oxide and propylene oxide to glycerin and then adding butylene oxide.

Gly- [O {(PO) x (EO) y} - (BO) zH] ₃ (I)

PO represents an oxypropylene group, EO represents an oxyethylene group, BO represents an oxybutylene group, and x represents an average addition mole number of PO (hereinafter referred to as " oxyglyceryl group " Y is an average addition mole number of EO, z is an average addition mole number of BO, x is 3 or more and 7 or less, y is 5 or more and 10 or less, and z is 1 or more and 5 or less.

The pretreatment agent for pharma according to the present embodiment contains polyoxybutylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8EO.) Represented by the following formula (Ia) as the glycerin derivative (I) (5P.O.) (cosmetic product name PEG / PPG / polybutylene glycol-8/5/3 glycerin) may be blended. The glycerin derivative is commercially available as " WILBRIDE S-753 "

Gly- [O {(PO) ₅ (EO) ₈ } - (BO) ₃ H] ₃ (Ia)

The total amount of the glycerin derivative (I) and the POP alkyl ether (II) in the pretreating agent for pharma treatment of the present embodiment is 4.0 mass% or less, so the amount of the glycerin derivative (I) is 4.0 mass% or less. When the total amount of the glycerin derivative (I) and the POP alkyl ether (II) is more than 4.0 mass%, the amount of the glycerin derivative (I) adhering to the surface of the hair becomes excessively large, There is a tendency.

POP alkyl ether (II)

The POP alkyl ether (II) is represented by the following general formula (II).

[In the above general formula (II), n represents 13 or more and 20 or less, and m represents an average addition mole number of 10 or more and 20 or less.

As the POP alkyl ether (II), for example, POP stearyl ether (11P.O.), POP stearyl ether (15P.O.), POP cetyl ether (10P.O.), POP cetyl ether (20P.O. ). The parenthesized integers following the illustrated POP alkyl ethers represent the average addition mole number of POPs.

Since the total amount of the glycerin derivative (I) and the POP alkyl ether (II) in the pretreatment for perm of the present embodiment is 4.0 mass% or less, the amount of the POP alkyl ether (II) is 4.0 mass% or less .

Arbitrary raw material

As described above, the arbitrary raw material to be mixed with the pretreatment agent for pharmacy of the present embodiment is appropriately selected from the raw materials to be compounded with the known pretreatment agent for perm. The raw material may be at least one selected from the group consisting of nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, polymer compounds, silicones, hydrocarbons, waxes, higher alcohols, polyhydric alcohols, fatty acids, Anti-inflammatory agents, preservatives, and perfumes.

When the pretreatment agent for pharma according to the present embodiment is in the form of a cream, for example, a higher alcohol and a cationic surfactant may be blended.

The higher alcohols may be those having a carbon number of 14 or more and 22 or less, and examples thereof include straight chain saturated alcohols such as myristyl alcohol, cetyl alcohol, stearyl alcohol, arachyl alcohol and behenyl alcohol; Linear unsaturated alcohols such as oleyl alcohol; And branched saturated alcohols such as hexyldecanol, octyldodecanol, isocetyl alcohol and isostearyl alcohol. One or more kinds of higher alcohols may be blended, and the blending amount of the higher alcohol in the pretreatment for perm of the present embodiment is, for example, 3% by mass or more and 8% by mass or less.

Examples of the cationic surfactant include di-long-chain alkyldimethylammonium salts such as distearyldimethylammonium chloride, dicetyldimethylammonium chloride and dicumyldimethylammonium chloride; Mono long chain alkyl trimethyl ammonium salts such as behenyl trimethyl ammonium chloride, behenyl trimethyl ammonium methosulfate, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium bromide and cetyl trimethyl ammonium bromide; And long-chain alkoxyalkyltrimethylammonium salts such as stearoxypropyltrimethylammonium chloride. (Here, the term "long-chain alkyl" as used herein means a straight-chain or branched alkyl group having a carbon number of not less than 8, Is preferable from the viewpoints of suppression of irritation to the skin and feeling given to the hair). One or more cationic surfactants may be blended, and the amount of the cationic surfactant incorporated in the pretreatment agent for pharma is, for example, 1% by mass or more and 5% by mass or less.

Formulation

Formulations for use in the pretreatment for perm are not particularly limited, and examples thereof include liquid, cream, wax, gel, foam (misty), misty and the like. The viscosity in the case of the cream phase formulation is, for example, 4000 mPa s or more and 30000 mPa s or less after 60 seconds measured at 25 DEG C using a rotor selected according to the viscosity in the B-type viscometer.

pH

The pH of the pretreatment agent for pharma according to the present embodiment is preferably 2.5 or more and 8.0 or less, more preferably 3.0 or more and 7.0 or less. With this pH range, it is suitable for suppressing disulfide bond cleavage in hair.

How to use

The pretreatment for perming agent of the present embodiment is applied to the hair before applying the first preparation for perming, such as the first preparation for shampooing, in the same manner as the known pretreatment for perming. The hair may or may not be washed between the application of the perming agent for the perm and the application of the first preparation for perm.

(First preparation for perm)

The first preparation for perming according to the second embodiment of the present invention is prepared by blending the glycerin derivative (I) or the POP alkyl ether (II), a reducing agent and an alkaline agent (the mixing amount of water is 50 mass% or more, for example). In addition, in the first pharmaceutical preparation of the present embodiment, a raw material to be blended with a known first pharmaceutical preparation is appropriately blended as an arbitrary raw material.

The glycerin derivative (I)

As described above, the glycerin derivative (I) is incorporated in the first pharmaceutical preparation of the present embodiment. Polyoxypropylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8EO.) (5PO.) (Represented by the above formula (Ia)) as the glycerin derivative (I) Cosmetic product name PEG / PPG / polybutylene glycol-8/5/3 glycerin) may be blended.

Since the total amount of the glycerin derivative (I) and the POP alkyl ether (II) in the first pharmaceutical preparation of the present embodiment is 4.0 mass% or less, the blending amount of the glycerin derivative (I) is 4.0 mass% or less. When the total amount of the glycerin derivative (I) and the POP alkyl ether (II) exceeds 4.0 mass%, the hair-shape deformation efficiency tends to deteriorate.

POP alkyl ether (II)

As described above, the POP alkyl ether (II) is incorporated in the first pharmaceutical preparation of the present embodiment. Examples of the POP alkyl ether (II) to be incorporated include POP stearyl ether (11 PO), POP stearyl ether (15 PO), POP cetyl ether (10 PO), POP cetyl ether .).

The total amount of the glycerin derivative (I) and the POP alkyl ether (II) in the first pharmaceutical preparation of the present embodiment is 4.0% by mass or less and the amount of the POP alkyl ether (II) is 4.0% by mass or less .

reducing agent

A reducing agent blended in a known first pharmaceutical preparation may be blended in the first pharmaceutical preparation of the present embodiment.

Examples of the reducing agent include thioglycolic acid, thioglycolic acid salt (ammonium thioglycolate, thioglycolic acid monoethanolamine), L-cysteine, L-cysteine hydrochloride, DL-cysteine, DL-cysteine hydrochloride, N- - cysteine, cysteamine, thio lactic acid, thioglycerin, and lactone thiol.

One or two or more kinds of reducing agents may be added to the first pharmaceutical preparation of the present embodiment. The amount of the reducing agent to be blended in the first pharmaceutical preparation should be appropriately set, but is, for example, 2% by mass or more and 12% by mass or less.

Alkaline agent

In order to increase the reducing power of the first pharmaceutical preparation for pharmacology of the present embodiment, a known first pharmaceutical preparation is formulated.

Examples of the alkaline agent include ammonia, aminoalcohols (such as monoethanolamine, triethanolamine, isopropanolamine, 2-amino-2-methyl-1-propanol, (Ammonium hydroxide, ammonium hydrogen phosphate, sodium monohydrogenphosphate, etc.), caustic alkali (potassium hydroxide, sodium hydroxide), basic amino acid (such as arginine), morpholine, carbonate (ammonium carbonate, ammonium bicarbonate, sodium bicarbonate, sodium bicarbonate, .

One or two or more kinds of alkaline agents may be blended into the first preparation for perm. Of the present embodiment. The blending amount of the alkali agent in the first pharmaceutical preparation may be an amount depending on the pH of the first preparation for perm.

Arbitrary raw material

As described above, the arbitrary raw material to be mixed with the first preparation for perming of the present embodiment is appropriately selected from the raw materials to be blended with the first known preparation for perming. The raw material may be at least one selected from the group consisting of nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, polymer compounds, silicones, hydrocarbons, waxes, higher alcohols, polyhydric alcohols, fatty acids, Anti-inflammatory agents, preservatives, and perfumes.

When the first pharmaceutical preparation of the present embodiment is in the form of a cream, for example, a higher alcohol and a cationic surfactant may be blended. Further, an anionic surfactant may be blended.

The higher alcohols may be those having a carbon number of 14 or more and 22 or less, and examples thereof include straight chain saturated alcohols such as myristyl alcohol, cetyl alcohol, stearyl alcohol, arachyl alcohol and behenyl alcohol; Linear unsaturated alcohols such as oleyl alcohol; And branched saturated alcohols such as hexyldecanol, octyldodecanol, isocetyl alcohol and isostearyl alcohol. One or more higher alcohols may be blended, and the blending amount of the higher alcohol in the first preparation for perm of the present embodiment is, for example, 3% by mass or more and 8% by mass or less.

Examples of the cationic surfactant include di-long-chain alkyldimethylammonium salts such as distearyldimethylammonium chloride, dicetyldimethylammonium chloride and dicumyldimethylammonium chloride; Mono long chain alkyl trimethyl ammonium salts such as behenyl trimethyl ammonium chloride, behenyl trimethyl ammonium methosulfate, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium bromide and cetyl trimethyl ammonium bromide; And long-chain alkoxyalkyltrimethylammonium salts such as stearoxypropyltrimethylammonium chloride. One or two or more cationic surfactants may be blended. The amount of the cationic surfactant to be incorporated in the first preparation for pharmacy of the present embodiment is, for example, 1% by mass or more and 5% by mass or less.

Examples of the anionic surfactant include carboxylic acid anionic surfactants such as N-acyl amino acid salts, fatty acid salts, alkyl ether carboxylates, fatty acid amide ether carboxylates, fatty acid amide ether carboxylic acids and acyl lactates; Phosphoric acid anionic surfactants such as alkyl phosphates, polyoxyethylene alkyl ether phosphates, alkyl aryl ether phosphates, and fatty acid amide ether phosphates; Sulfosuccinic acid salts,? -Olefin sulfonic acid salts,? -Sulfo fatty acid methyl ester salts, acyl isethionates, alkyl glycidyl ether sulfonic acid salts, alkylsulfo succinic acid salts, alkylsulfonic acid salts, alkylbenzenesulfonic acid salts, alkylnaphthalenesulfonic acid salts , N-acylmethyltaurine salts and the like; Sulfuric acid anionic surfactants such as alkyl sulfates, alkyl ether sulfates, alkyl aryl ether sulfates, fatty acid alkanolamide sulfates, and fatty acid monoglyceride sulfates. One or more anionic surfactants may be blended, and the blending amount of the anionic surfactant in the first pharmaceutical preparation of the present embodiment is, for example, 1% by mass or more and 5% by mass or less.

Formulation

The formulation when the first pharmaceutical preparation is used is not particularly limited, and examples thereof include a liquid, a cream, and a gel. The viscosity in the case of the cream phase formulation is, for example, 4000 mPa s or more and 30000 mPa s or less after 60 seconds measured at 25 DEG C using a rotor selected according to the viscosity in the B-type viscometer.

pH

The pH of the first pharmaceutical preparation of the present embodiment is, for example, alkaline having a pH of 11.0 or less and preferably 8.0 or more and 10.0 or less.

How to use

The first preparation for perming of the present embodiment may be used in the same manner as the known method of using the two-component emulsifying agent and may be used in the same manner as the known method of using the single-use emollient. That is, the first preparation of the cold type of formula-free wave which does not involve heating, the first preparation of the warm-up type two-type wave form accompanied by the heating at 60 DEG C or less, the cold type one-type wave form, It may be used as the first preparation of the two-component shampoo proofing agent, the first preparation of the warming-type shampoo shampoo proofing agent, or the first preparation of the two-component shampoo proofing agent using the high-temperature ironing device of about 180 ° C.

The second preparation in the case of using the first preparation for perming of this embodiment as the first preparation of the second preparation is not particularly limited as long as it contains a known oxidizing agent and an optional raw material. The oxidizing agent to be incorporated is, for example, a bromate (sodium bromate, potassium bromate, etc.) or hydrogen peroxide. The optional raw materials may be selected from the group consisting of nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, polymer compounds, silicones, hydrocarbons, waxes, higher alcohols, polyhydric alcohols, fatty acids, , Chelating agents, anti-inflammatory agents, preservatives, perfumes, and the like. The pH of the second preparation is, for example, not less than 5.0 and not more than 8.0 when a bromate is compounded, and not less than 2.0 and not more than 4.0, for example, when hydrogen peroxide is compounded.

[Example]

Hereinafter, the present invention will be described in detail on the basis of examples, but the present invention is not limitedly interpreted based on the description of this example.

(Example 1, Comparative Examples 1a to 1f)

Water, polyoxybutylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8PO) (5PO.), Diethyl naphthalenedicarboxylate, glutathione, ammonium dithiodiglycolate , Ethoxydiglycol, isopropanol, POE cetyl ether (30E.O.), and monostearic acid polyoxyethylene glycol were mixed to prepare a pretreatment for liquid phase perming agent of Example 1 and Comparative Examples 1a to 1f The compounding concentrations of the raw materials combined with water are as shown in Table 1 below).

Approximately 1 g of the pretreatment agent for Example 1 was applied to a hair blotter (approximately 2 g, black wavy pattern of about 40 cm) wiped with a shampoo and wiped with a towel, And subjected to perming treatment with a correction agent. As a comparison of the perming treatment, the pretreatment of the perming pretreatment agent of Example 1 was replaced by the pretreatment agent for the perming agents of Comparative Examples 1a to 1f and the treatment without the perming pretreatment agent was performed.

In the above-mentioned perm treatment, a commercially available first formulation for wax correction ("Liscio GLANFE VD-H first formulation" manufactured by Mirborn Co., Ltd.) and a second formulation for wax correction ("Liscio GLANFE second formulation" Respectively. The order in the perming process was as follows. 2 g of the first formulation for shamanism correction was applied to the hair, allowed to stand for about 20 minutes, washed with water, and dried. Subsequently, the hair was spread by using a pair of ironing blades (plate setting temperature: 180 DEG C) equipped with a pair of plates for clamping the hair bundle, and about 2 g of the second preparation for sham-eye correction was applied. , Washed with water and dried.

(evaluation)

The percentage of " spreading hair " in the hair of the hair was calculated as an evaluation of the deformation efficiency of the hair shape by using each of the above-mentioned perming prepara- tors. The concrete procedure for this calculation was as follows. When the upper part of one hair after treatment with water impregnated with a water was fixed and naturally dried and the hair confirmed by the naked eye was almost straight, it was recognized as " extended hair ". This recognition work was performed on 100 hairs.

As an evaluation of the reduction of the hair damage, the percentage of the "damaged hair" in the hair was calculated. This calculation is based on the assumption that the hair that can be visually recognized by the naked eye and the hair which is not smooth in texture are recognized as " high-damaged hair " Dog hair.

The following Table 1 shows the percentages of the " spreading hairs " calculated for evaluating the raw materials and the blending amount and the deformation efficiency of hair shape for the preparation of the pretreatment agent for pharma example of Example 1 and Comparative Examples 1a to 1f, And the percentage of " high-damaged hair " calculated to evaluate the reduction of hair damage.

In Table 1, only Example 1 in which the glycerin derivative (I) was blended was different from Comparative Examples 1a to 1f, and the ratio of the damaged hair was lower than that of the expanded hair. That is, in the comparative example, the ratio of the damaged hair tends to be higher when the ratio of the expanded hair is higher (in particular, the comparative examples 1e to 1f), but the tendency of the proportion of the damaged hair to be increased is reduced in the first embodiment have.

(Example 2, Comparative Examples 2a to 2b)

Water, and POP stearyl ether (15P.O.), POE.POP butyl ether (9E.O.) (10P.O.), polyoxyethylene glyceryl monostearate (5E.O.), POE cetyl ether 30E.O.) and polyoxyethylene glycol monostearate were mixed to prepare a pretreatment agent for liquid pharma in Example 2 and Comparative Examples 2a to 2b (the compounding concentration of the raw material compounded with water was as follows: As shown in Table 2).

As in Example 1 and the like, the pretreatment agent for Pharma of Example 2 and Comparative Examples 2a to 2b was evaluated. In addition, the hair used in the evaluation here was obtained from a hair which is different from the hair-derived person used in Example 1.

The following Table 2 shows the results of the raw materials and blending amount and the "extended hair" and "high-damaged hair" formulated with water for the preparation of the pretreatment agent for pharma example of Example 2 and Comparative Examples 2a to 2b.

In Table 2, only Example 2 in which the POP alkyl ether (II) was blended was different from Comparative Examples 2 a and 2 b, and the rate of the high damaged hair was low, while the ratio of the expanded hair was high.

(Example 3, Comparative Examples 3a-b)

Water, and polyoxybutylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8EO.) (5PO.), POP stearyl ether (15PO.), POE cetyl ether 30E.O.), and polyoxyethylene glycol monostearate were mixed to prepare a pretreatment agent for liquid phase perm in Example 3 and Comparative Examples 3a to 3b (the compounding concentration of the raw material compounded with water was as follows: As shown in Table 3).

As in Example 1 and the like, the pretreatment agent for Pharma of Example 3 and Comparative Examples 3a to 3b was evaluated. In addition, the hair used in the evaluation in this example was taken from a hair different from the hair-derived person used in Examples 1 and 2.

The following Table 3 shows the results of the raw materials and blending amount and the "extended hair" and "high-damaged hair" formulated with water for the preparation of the pretreatment agent for pharma example of Example 3 and Comparative Examples 3a to 3b.

In Table 3, in Comparative Examples 3a and 3b in which the blending amount of the glycerin derivative (I) and the POP alkyl ether (II) was more than 4.0% by mass, the ratio of the spreading hairs tended to be lower than that in the case where the pretreatment was not performed Respectively. On the other hand, in Example 3 in which the blending amount is 4.0 mass% or less, the ratio of the spreading hair is high.

(Examples 4a to 4b, Comparative Example 4)

Water, and polyoxybutylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8EO.) (5P. O.), POP stearyl ether (15PO.), POE stearyl ether , Stearyltrimethylammonium chloride, POE cetyl ether phosphoric acid, dicetyl phosphate, cetostearyl alcohol, myristyl alcohol, isopropyl palmitate, soft lanolin fatty acid cholesteryl, cationized cellulose, silicone, dipropylene glycol, isopropanol, thioglycol The ingredients selected from the group consisting of ammonium, thioglycolic acid monoethanolamine, dibenzoyldiethanolamine, monoethanolamine, monoethanolamine, ammonium hydrogen carbonate, chelating agents, and fragrances were combined to prepare creamy toppers of Examples 4a to 4b and Comparative Example 4 (The compounding concentration of the raw material combined with water is as shown in Table 4 below).

The perming treatment was carried out using the first preparation for perms of Examples 4a to 4b and Comparative Example 4. In this perming treatment, a commercially available first formulation for wax correction ("Liscio GLANFE VD-H first formulation" manufactured by Mirborn Corporation) and a second formulation for wax correction ("Liscio GLANFE second formulation" Respectively. In the perming treatment, the first formulation for shamanistic correction of about 2 g was applied to a cleaned hair, allowed to stand for about 20 minutes, washed with water, and then dried. Then, The hair was spread using an iris (plate setting temperature: 180 ° C) for calibration, and about 2 g of the second formulation for sham-eye correction was applied, left for 5 minutes, washed with water and dried.

For the hair after the perming treatment using the first preparation for perms of Examples 4a to 4b and Comparative Example 4, the percentages of "extended hair" and "highly damaged hair" were calculated in the same manner as in Example 1.

Table 4 below shows the results of the raw materials and blending amount and the " extended hair " and " damaged hair " combined with water for preparation of the first pharmaceutical preparation of Examples 4a to 4b and Comparative Example 4.

In Examples 4a to 4b in which the glycerin derivative (I) or the POP alkyl ether (II) was blended in Table 4, the percentage of hair expanded was higher than that of Comparative Example 4, Ratio. That is, by blending the glycerin derivative (I) or the POP alkyl ether (II) into the first pharmaceutical preparation, hair damage was reduced and the hair-shape deformation efficiency was improved.

Claims (3)

A hair treatment agent used as a first preparation for perms containing a pretreatment agent for pharma or a reducing agent,
A glycerin derivative (I) represented by the following general formula (I) or a polyoxypropylene alkyl ether (II) represented by the following general formula (II)
Wherein the blending amount of the glycerin derivative (I) and the polyoxypropylene alkyl ether (II) is 4.0 mass% or less.
Gly- [O {(PO) x (EO) y} - (BO) zH] ₃ (I)
PO represents an oxypropylene group, EO represents an oxyethylene group, BO represents an oxybutylene group, and x represents an average addition mole number of PO (hereinafter referred to as " PO " Y is an average addition mole number of EO, z is an average addition mole number of BO, x is 3 or more and 7 or less, y is 5 or more and 10 or less, and z is 1 or more and 5 or less.

[In the above general formula (II), n represents 13 or more and 20 or less, and m represents an average addition mole number of 10 or more and 20 or less. The polyoxyethylene polyoxypropylene polyoxyethylene polyoxypropylene glyceryl ether (3BO) (8EO) (5P) represented by the following formula (Ia) is used as the glycerin derivative (I) O.).
Gly- [O {(PO) ₅ (EO) ₈ } - (BO) ₃ H] ₃ (Ia) The hair treatment agent according to any one of claims 1 to 3, which is used as a pretreatment agent for hair loss correction or as a first agent for hair loss correction.